Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aiyan Xing"'
Autor:
Juan Zhou, Miao Duan, Qiong Jiao, Chunyan Chen, Aiyan Xing, Peng Su, Juan Tang, Hui Zhang, Zhiyan Liu
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundNuclear protein in testis (NUT) carcinoma (NC) is a rare and aggressive undifferentiated carcinoma that typically arises from midline supradiaphragmatic structures. It is uniquely driven by a NUT gene rearrangement on chromosome 15q14. Few
Externí odkaz:
https://doaj.org/article/14c0d82a5b37485e8dc27b7c05d3b57e
Autor:
Wenbin Li, PhD, Yunfeng Lyu, PhD, Shaoming Wang, PhD, Xiaoyan Zhou, MD, PhD, Jie Ma, MD, Chao Xu, MS, Li Fang, MS, Jianming Ying, MD, PhD, Lei Guo, Tian Qiu, Weihua Li, Yan Li, Nanying Che, Xuefeng Bai, Yanfeng Xi, Yanping Hu, Liping Liu, Xuemei Li, Shujun Zhang, Hongxue Meng, Xiumei Duan, Yan Wu, Lian He, Nan Liu, Jie He, Hong Li, Zhihui Yang, Jie Lin, Yi Shi, Xiaoyan Li, Meihong Yao, Qianming Bai, Ling Xie, Xinghua Zhu, Aiyan Xing, Zebing Liu, Lei Dong, Wentao Huang, Jie Huang, Guohua Yu, Xiaotong Hu, Dan Su, Bing Wei, Fang Guo, Ziguang Xu, Guozhong Jiang, Qian Cui, Jia Li, Xianhua Xu, Juan Jiao, Xinhui Fu, Nengtai Ouyang, Xiaojuan Li, Xiaoying Zhu, Yanjie Liu, Qiushi Wang, Qiong Liao, Zhuo Zuo, Tao Luo, Chenggang Yang, Xiaoming Wang, Xi Liu, Wenli Cui
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 4, Pp 100163- (2021)
Introduction: Lung cancer is the leading cause of cancer-related morbidity and mortality in the People’s Republic of China. Targeted therapies for patients with lung cancer, which depend on accurate identification of actionable genomic alteration,
Externí odkaz:
https://doaj.org/article/bf4a443817d748a39725c0d958e4f8e9
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Endometriosis is one of the most common benign gynecological diseases. It shows similar attributes to those of some fatal tumors if it is becomes malignant. These attributes include invasion, implantation, and recurrence. Epidemiological, clinicopath
Externí odkaz:
https://doaj.org/article/376583f90dfd4fa9b64b166b5f0c14fe
Autor:
Yunfeng Lyu, Hong Li, Xuemei Li, Dan Su, Weihua Li, Yanjie Liu, Jie Ma, Nengtai Ouyang, Yanping Hu, Qian Cui, Jie Lin, Yan Wu, Lei Guo, Jianming Ying, Qiushi Wang, Xiaotong Hu, Jie Huang, Wenbin Li, Xiaoyan Li, Lei Dong, Xiumei Duan, Nan Liu, Wenli Cui, Wentao Huang, Jia Li, Xiaoming Wang, Xianhua Xu, Chenggang Yang, Xuefeng Bai, Qiong Liao, Nanying Che, Yanfeng Xi, Tao Luo, Lian He, Xiaoying Zhu, Yi Shi, Ziguang Xu, Meihong Yao, Guozhong Jiang, Zhuo Zuo, Shujun Zhang, Xinhui Fu, Yan Li, Shaoming Wang, Fang Guo, Liping Liu, Qianming Bai, Juan Jiao, Hongxue Meng, Ling Xie, Xiaoyan Zhou, Tian Qiu, Zebing Liu, Aiyan Xing, Chao Xu, Zhihui Yang, Guohua Yu, Li Fang, Xinghua Zhu, Bing Wei, Xi Liu, Jie He, Xiaojuan Li
Publikováno v:
JTO Clinical and Research Reports
JTO Clinical and Research Reports, Vol 2, Iss 4, Pp 100163-(2021)
JTO Clinical and Research Reports, Vol 2, Iss 4, Pp 100163-(2021)
Introduction: Lung cancer is the leading cause of cancer-related morbidity and mortality in the People’s Republic of China. Targeted therapies for patients with lung cancer, which depend on accurate identification of actionable genomic alteration,
Publikováno v:
Journal of Cancer Research and Therapeutics. 18:445
Invasive mucinous adenocarcinoma (IMA) is a distinct variant of lung adenocarcinoma, which typically has a worse survival. However, its pathogenesis is potentially associated with a high degree of molecular heterogeneity, which might determine its di